<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05040516</url>
  </required_header>
  <id_info>
    <org_study_id>KB-39/2020</org_study_id>
    <nct_id>NCT05040516</nct_id>
  </id_info>
  <brief_title>Selenoprotein and Renalase Blood Levels in Patients With Hypertensive Heart Disease and Obstructive Sleep Apnea</brief_title>
  <official_title>The Role of Selenoprotein Activity and Blood Renalase Level in the Pathogenesis of Hypertension and Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wroclaw Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wroclaw Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to determine whether selenoprotein activity and blood renalase level&#xD;
      correlate with subclinical hypertensive heart disease and obstructive sleep apnea. The&#xD;
      correlation will be assessed using selected electrocardiographic, ultrasound and laboratory&#xD;
      indicators.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be conducted in the Department and Clinic of Internal Medicine, Occupational&#xD;
      Diseases, Hypertension and Clinical Oncology at Borowska 213 street in Wroclaw. This decision&#xD;
      follows the high percentage of people with obstructive sleep apnea and hypertension among&#xD;
      those hospitalized in the Clinic and also the wide availability of research tools in the&#xD;
      hospital.&#xD;
&#xD;
      150 more patients with hypertension and obstructive sleep apnea will be included in the&#xD;
      planned observational study.&#xD;
&#xD;
      The study is observational, research procedures are non-invasive and no additional medical&#xD;
      experiment is planned. The study was approved by the Bioethics Committee of the Wroclaw&#xD;
      Medical University.&#xD;
&#xD;
      Patients enrolled in the study will be asked to share the results of their previously&#xD;
      performed examinations or, in case they do not have any, new examinations will be performed&#xD;
      to complement the diagnostic process of hypertension and obstructive sleep apnea.&#xD;
&#xD;
      The planned procedures include: medical interview, physical examination with basic&#xD;
      anthropometric measurements (age, height, body weight); biochemical tests including blood&#xD;
      selenium, selenoproteins, renalase and creatinine levels; total antioxidant status (TAS),&#xD;
      24-hour Holter electrocardiography, polysomnography, ultrasound assessment of peripheral&#xD;
      vascular endothelial function and echocardiography.&#xD;
&#xD;
      Laboratory tests will be performed using commercially available standardized tests. The&#xD;
      levels of selenoproteins, renalase and creatinine in the blood, as well as TAS will be&#xD;
      determined by ELISA (Enzyme-linked immunosorbent assay) in accordance with the instructions.&#xD;
      Blood selenium level will be measured by means of atomic absorption spectrometry (AAS).&#xD;
      24-hour Holter ECG monitoring will be performed using a Lifecard CF recorder, followed by an&#xD;
      analysis of the record by the Impresario Solo system (Delmar Reynolds, Hertford, UK).&#xD;
      Ultrasound examination will be performed using the ProSound Alpha 6 (Aloka Inc, Tokyo,&#xD;
      Japan).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 27, 2020</start_date>
  <completion_date type="Anticipated">October 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>3 Days</target_duration>
  <primary_outcome>
    <measure>Assesment of blood renalase level</measure>
    <time_frame>One day</time_frame>
    <description>The Enzyme-linked immunosorbent assay (ELISA) to know blood renalase level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assesment of blood selenoprotein P level</measure>
    <time_frame>One day</time_frame>
    <description>The Enzyme-linked immunosorbent assay (ELISA) to know blood selenoprotein P level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assesment of the severity of obstructive sleep apnea</measure>
    <time_frame>One day</time_frame>
    <description>Full polysomnography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of arrhythmias</measure>
    <time_frame>One day</time_frame>
    <description>24-hour Holter ECG monitoring</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of arrhythmias and cardiac morphology</measure>
    <time_frame>One day</time_frame>
    <description>Echocardiography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assesment of Blood Total Antioxidant Status (TAS)</measure>
    <time_frame>One day</time_frame>
    <description>The Enzyme-linked immunosorbent assay (ELISA) to know Blood Total Antioxidant Status (TAS)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Hypertension</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>The planned procedures include: medical interview, physical examination with basic anthropometric measurements (age, height, body weight); biochemical tests including blood selenium, selenoproteins, renalase and creatinine levels; total antioxidant status (TAS), 24-hour Holter electrocardiography, polysomnography and echocardiography.&#xD;
A 10 ml of venous blood sample will be collected by venopuncture. Laboratory tests will be performed using commercially available standardized tests.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      10 ml of venous blood collected by venopuncture&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Study participants will be recruited among the patients of the Department of Internal and&#xD;
        Occupational Diseases, Hypertension and Clinical Oncology in Wroclaw. 150 more consecutive&#xD;
        patients with hypertension and obstructive sleep apnea will be included in the planned&#xD;
        observational study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  arterial hypertension&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age &lt;18&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  refusal to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paweł Gać, ASSOC PROF</last_name>
    <role>Study Chair</role>
    <affiliation>Wroclaw Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karolina Czerwińska, MD</last_name>
    <phone>+48 790 404 619</phone>
    <email>karolina.czerwinska@student.umed.wroc.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paweł Gać, ASSOC PROF</last_name>
    <phone>+48 71 784 15 01</phone>
    <email>pawel.gac@umed.wroc.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Hygiene, Wroclaw Medical University</name>
      <address>
        <city>Wrocław</city>
        <state>Dolnośląskie</state>
        <zip>50-368</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paweł Gać, ASSOC PROF</last_name>
      <phone>+48 71 784 15 01</phone>
      <email>pawel.gac@umed.wroc.pl</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 9, 2021</study_first_submitted>
  <study_first_submitted_qc>September 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 10, 2021</study_first_posted>
  <last_update_submitted>September 1, 2021</last_update_submitted>
  <last_update_submitted_qc>September 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hypertension</keyword>
  <keyword>renalase</keyword>
  <keyword>selenoprotein</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

